Published in AIDS Weekly, February 9th, 2004
This program provides CytRx with worldwide commercial rights under an exclusive license with UMMS to any potential products that are developed based on this cutting-edge technology. It has been estimated that the healthcare burden of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.